Morphotek, Inc. - Product Pipeline Review - 2015 - Product Image

Morphotek, Inc. - Product Pipeline Review - 2015

  • ID: 3387854
  • Company Profile
  • 40 pages
  • Global Markets Direct
  • Morphotek
1 of 3
Morphotek, Inc. - Product Pipeline Review - 2015

Summary

The report ‘Morphotek, Inc. - Product Pipeline Review - 2015’, provides an overview of the Morphotek, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Morphotek, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updates following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Morphotek, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Morphotek, Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Morphotek, Inc.’s pipeline products

Reasons to buy

- Evaluate Morphotek, Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Morphotek, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Morphotek, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Morphotek, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Morphotek, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Morphotek, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
READ MORE
Note: Product cover images may vary from those shown
2 of 3
List of Tables
List of Figures
Morphotek, Inc. Snapshot
Morphotek, Inc. Overview
Key Information
Key Facts
Morphotek, Inc. - Research and Development Overview
Key Therapeutic Areas
Morphotek, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Morphotek, Inc. - Pipeline Products Glance
Morphotek, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Morphotek, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Morphotek, Inc. - Drug Profiles
amatuximab
Product Description
Mechanism of Action
R&D Progress
farletuzumab
Product Description
Mechanism of Action
R&D Progress
ontuxizumab
Product Description
Mechanism of Action
R&D Progress
KANAb-071
Product Description
Mechanism of Action
R&D Progress
MORAb-022
Product Description
Mechanism of Action
R&D Progress
MORAb-066
Product Description
Mechanism of Action
R&D Progress
MORAb-047
Product Description
Mechanism of Action
R&D Progress
MORAb-048
Product Description
Mechanism of Action
R&D Progress
MORAb-050
Product Description
Mechanism of Action
R&D Progress
MORAb-075
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody Conjugates for Cancer
Product Description
Mechanism of Action
R&D Progress
Morphotek, Inc. - Pipeline Analysis
Morphotek, Inc. - Pipeline Products by Target
Morphotek, Inc. - Pipeline Products by Route of Administration
Morphotek, Inc. - Pipeline Products by Molecule Type
Morphotek, Inc. - Pipeline Products by Mechanism of Action
Morphotek, Inc. - Recent Pipeline Updates
Morphotek, Inc. - Dormant Projects
Morphotek, Inc. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Morphotek, Inc., Key Information
Morphotek, Inc., Key Facts
Morphotek, Inc. - Pipeline by Indication, 2015
Morphotek, Inc. - Pipeline by Stage of Development, 2015
Morphotek, Inc. - Monotherapy Products in Pipeline, 2015
Morphotek, Inc. - Phase II, 2015
Morphotek, Inc. - Phase I, 2015
Morphotek, Inc. - Preclinical, 2015
Morphotek, Inc. - Discovery, 2015
Morphotek, Inc. - Pipeline by Target, 2015
Morphotek, Inc. - Pipeline by Route of Administration, 2015
Morphotek, Inc. - Pipeline by Molecule Type, 2015
Morphotek, Inc. - Pipeline Products by Mechanism of Action, 2015
Morphotek, Inc. - Recent Pipeline Updates, 2015
Morphotek, Inc. - Dormant Developmental Projects,2015

List of Figures
Morphotek, Inc. - Pipeline by Top 10 Indication, 2015
Morphotek, Inc. - Pipeline by Stage of Development, 2015
Morphotek, Inc. - Monotherapy Products in Pipeline, 2015
Morphotek, Inc. - Pipeline by Top 10 Target, 2015
Morphotek, Inc. - Pipeline by Top 10 Route of Administration, 2015
Morphotek, Inc. - Pipeline by Top 10 Molecule Type, 2015
Morphotek, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll